ADXN Addex Therapeutics Ltd.
Nasdaq · SEC CIK 1574232 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 8 since 2026-09-04, latest 2026-09-04 16:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kalinichev Mikhail | HEAD OF TRANSLATIONAL SCIENCE | — | — |
| Lawton Vincent Michael | Dir | — | — |
| Hill Raymond George | Dir | — | — |
| Dyer Timothy Mark | CEO, Dir | — | — |
| Manke Isaac | Dir | — | — |
| Nunn Jason Raleigh | Dir | — | — |
| Mills Roger | Chief MEDICAL Off, Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-04 16:09 | 2026-09-02 | ADXN | Kalinichev Mikhail | HEAD OF TRANSLATIONAL SCIENCE | D - Sale to Iss | $0.00 | -306.8K | 0 | -100% | $0 |
| D | 2026-09-04 16:09 | 2026-09-02 | ADXN | Kalinichev Mikhail | HEAD OF TRANSLATIONAL SCIENCE | A - Grant | $0.00 | +306.8K | 306.8K | New | $0 |
| D | 2026-09-04 16:06 | 2026-09-02 | ADXN | Nunn Jason Raleigh | Dir | D - Sale to Iss | $0.00 | -219.6K | 0 | -100% | $0 |
| D | 2026-09-04 16:06 | 2026-09-02 | ADXN | Nunn Jason Raleigh | Dir | A - Grant | $0.00 | +219.6K | 219.6K | New | $0 |
| D | 2026-09-04 16:05 | 2026-09-02 | ADXN | Mills Roger | Chief MEDICAL Off, Dir | D - Sale to Iss | $0.00 | -392.8K | 393.1K | -50% | $0 |
| D | 2026-09-04 16:05 | 2026-09-02 | ADXN | Mills Roger | Chief MEDICAL Off, Dir | A - Grant | $0.00 | +392.8K | 786.0K | +100% | $0 |
| D | 2026-09-04 16:03 | 2026-09-02 | ADXN | Manke Isaac | Dir | D - Sale to Iss | $0.00 | -219.6K | 0 | -100% | $0 |
| D | 2026-09-04 16:03 | 2026-09-02 | ADXN | Manke Isaac | Dir | A - Grant | $0.00 | +219.6K | 219.6K | New | $0 |
| D | 2026-09-04 16:02 | 2026-09-02 | ADXN | Lawton Vincent Michael | Dir | D - Sale to Iss | $0.00 | -2.51M | 500 | -100% | $0 |
| D | 2026-09-04 16:02 | 2026-09-02 | ADXN | Lawton Vincent Michael | Dir | A - Grant | $0.00 | +2.51M | 2.51M | +501,497% | $0 |
| D | 2026-09-04 16:01 | 2026-09-02 | ADXN | Hill Raymond George | Dir | D - Sale to Iss | $0.00 | -1.37M | 0 | -100% | $0 |
| D | 2026-09-04 16:01 | 2026-09-02 | ADXN | Hill Raymond George | Dir | A - Grant | $0.00 | +1.37M | 1.37M | New | $0 |
| D | 2026-09-04 16:00 | 2026-09-02 | ADXN | Dyer Timothy Mark | CEO, Dir | D - Sale to Iss | $0.00 | -16.41M | 435.2K | -97% | $0 |
| D | 2026-09-04 16:00 | 2026-09-02 | ADXN | Dyer Timothy Mark | CEO, Dir | A - Grant | $0.00 | +16.41M | 16.85M | +3,772% | $0 |
Purchase Sale Sale after option exercise All abbreviations